How Genome Clinical Grade Data is Improving Genomics in the US
San Francisco-based Genome Medical is making genetic care accessible to patients. According to HealthCare IT News, the medical facility is leveraging Genome clinical grade data to provide genetic services 7 days a week.
Genome Medical partners with molecular testing labs, health systems, and life science organizations to expand the impact and practice of genomic medicine for better patient care.
These partnerships are enabling the medical facility to find clinical trial patients that match ultra-rare ailments clinical requirements.
Additionally, Genome Medical works with bio-pharmaceutical companies to accelerate the design, development,and launch of life-supporting therapeutics. The medical facility is turning the tide of a hefty, slow process with its vast clinical and genetics experience and solid patient relationships.
Genome Medical Clinical Grade Data
Genome Medical has partnered with xCures to generate medical clinical grade data. xCures transforms different formats of medical data into clinical-grade formatted data for use by physicians and patients.
Genome Medical CEO, Jill Davies said, “Partnering with xCures provided us an opportunity to help our partners further accelerate clinical trials by identifying clinically qualified trial participants. With xCures, we are able to augment the patient data we already have – adding more robust patient clinical histories from the EHR, such as diagnoses, medications, prior treatments and more.”
The partnership with xCures gives Genome Medical access to a secure search platform and health information exchanges. This allows the facility to access patient records within minutes.
“By appending additional clinical data to each record via xCures, we have a robust and continuously growing patient population to identify and activate for clinical trials,” Davies explained.
National Genetic Specialist Network
Genome Medical says it has a country-wide network of genetic specialists whose clinical experience averages 10 years. This network features a wide spectrum of genetic specialties that include pediatrics, reproductive health, oncology, cardiology, and rare disease.
“This positions us to help our partners and their patients navigate the often intimidating and confusing diagnostic journey to find a clinical trial or genetic therapy that helps them better manage their health condition,” Jill Davies said.
Clinical Trial Participants
Genome Medical identifies participants for clinical trials with relative ease. Every month, the medical facility provides genetic counseling to 6,000+ patients. The clinical records of patients are maintained and reviewed to identify qualified patients.
“During our patient intake process for providing genetic counseling services we are able to give patients an option to be recontacted by Genome Medical if we become aware of a clinical trial that is relevant to their clinical condition,” Davies noted.
For instance, the facility reported that it identified 7 eligible patients for a clinical trial that required participants for a rare disease that affects 1 in 70 to 100 thousand people. Genome Medical also identified 33 patients to participate in an oncology clinical trial. The trial required patients who had been excluded in previous treatments but demonstrated particular genetic markers.
